A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

NCT00403481 ·Status: COMPLETED ·Phase: PHASE4

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

NCT00931710 ·Status: COMPLETED ·Phase: PHASE4

Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

NCT01152567 ·Status: COMPLETED

The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)

NCT00856960 ·Status: COMPLETED ·Phase: PHASE1

Antiproteinuric Effect of Valsartan and Lisinopril

NCT00171574 ·Status: COMPLETED ·Phase: PHASE4

To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

NCT00550095 ·Status: COMPLETED ·Phase: PHASE4

Antialbuminuric Effects of Valsartan and Lisinopril

NCT00171600 ·Status: TERMINATED ·Phase: PHASE4

Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes

NCT01011062 ·Status: COMPLETED ·Phase: NA

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

NCT00171119 ·Status: TERMINATED ·Phase: PHASE4

Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

NCT01681576 ·Status: COMPLETED ·Phase: PHASE2

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

NCT00856271 ·Status: COMPLETED ·Phase: PHASE3

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

NCT00394745 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

NCT02620306 ·Status: COMPLETED ·Phase: PHASE3

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

NCT00464880 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

NCT01447485 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

NCT00400218 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

NCT00241072 ·Status: COMPLETED ·Phase: PHASE4

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

NCT00887588 ·Status: COMPLETED ·Phase: PHASE2

Olmesartan Medoxomil in Hypertension and Renal Impairment

NCT00151827 ·Status: COMPLETED ·Phase: PHASE3

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

NCT00716950 ·Status: UNKNOWN ·Phase: PHASE4

Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy

NCT00464776 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

NCT00190580 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

NCT05843162 ·Status: UNKNOWN ·Phase: PHASE4

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

NCT03250052 ·Status: COMPLETED ·Phase: PHASE1

Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

NCT05001945 ·Status: COMPLETED ·Phase: PHASE2